All In MedTech

FDA Clearance Tracker · P130004-S008

ReSure Sealant

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 5, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 5, 2020

Approved

Time to decision

146 days

Received Dec 11, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P130004-S008
Device name
ReSure Sealant
Applicant location
Bedford, MA
Received
Dec 11, 2019
Decided
May 5, 2020
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P130004

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code PFZ

FDA's approval statement

As written in FDA's record.

Approval of the revised protocol for the post-approval study (PAS), Device Exposure Registry Study.

Source documents

Other decisions for Ocular Therapeutix, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.